FibroGENE: A gene-based model for staging liver fibrosis.
暂无分享,去创建一个
Thomas Berg | Manuel Romero-Gómez | Duncan McLeod | David R. Booth | Olfat G. Shaker | Wendy Cheng | William L. Irving | Christopher Liddle | D. Booth | T. Berg | A. Mangia | G. Ahlenstiel | J. Nattermann | U. Spengler | H. Chan | S. Riordan | G. Dore | W. Irving | J. Ampuero | O. Shaker | M. Weltman | J. George | E. Bugianesi | L. Miele | J. Fischer | C. Liddle | M. Douglas | L. Adams | M. Eslam | E. Powell | Gregory J. Dore | Golo Ahlenstiel | Martin Weltman | Maria Lorena Abate | Ulrich Spengler | David Sheridan | Jacob George | Janett Fischer | A. Hashem | W. Cheng | Luca Miele | Mohammed Eslam | Ahmed M. Hashem | Alessandra Mangia | Henry Lik-Yuen Chan | Leon A. Adams | Elisabetta Bugianesi | Lindsay Mollison | Jacob Nattermann | Stephen M. Riordan | Kebitsaone Simon Kelaeng | Javier Ampuero | Elizabeth E. Powell | Mark W. Douglas | D. Sheridan | L. Mollison | M. Abate | M. Romero‐Gomez | D. McLeod
[1] Mats Fredrikson,et al. Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up , 2015, Hepatology.
[2] V. Wong,et al. Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease , 2015, Nature Communications.
[3] D. Booth,et al. IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection. , 2014, Journal of hepatology.
[4] E. Álvarez,et al. Prediction of Hepatic Fibrosis in Patients Coinfected With HIV and Hepatitis C Virus Based on Genetic Markers , 2013, Journal of acquired immune deficiency syndromes.
[5] J. Talwalkar,et al. AASLD clinical practice guidelines: A critical review of scientific evidence and evolving recommendations , 2013, Hepatology.
[6] R. Schiumerini,et al. Review article: the diagnosis of non‐alcoholic fatty liver disease – availability and accuracy of non‐invasive methods , 2013, Alimentary pharmacology & therapeutics.
[7] V. Wong,et al. Tu1036 The Cirrhosis Risk Score is Not Associated With Liver Fibrosis/Cirrhosis and Fibrosis Progression in Chinese Non-Alcoholic Fatty Liver Disease Patients , 2012 .
[8] Ahmed M. Hashem,et al. Single stage and multistage classification models for the prediction of liver fibrosis degree in patients with chronic hepatitis C infection , 2012, Comput. Methods Programs Biomed..
[9] B. Bravenboer,et al. The diagnosis of non‐alcoholic fatty liver disease , 2012, Alimentary pharmacology & therapeutics.
[10] N. Enomoto,et al. Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors. , 2011, Journal of hepatology.
[11] V. de Lédinghen,et al. Transient elastography and biomarkers for liver fibrosis assessment and follow‐up of inactive hepatitis B carriers , 2011, Alimentary pharmacology & therapeutics.
[12] A. Feldstein,et al. Nonalcoholic steatohepatitis: risk factors and diagnosis , 2010, Expert review of gastroenterology & hepatology.
[13] G. Fattovich,et al. A seven‐gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C , 2009, Hepatology.
[14] J. Sninsky,et al. Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease. , 2009, Journal of hepatology.
[15] Pierre Bedossa,et al. Non‐invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B , 2009, Liver international : official journal of the International Association for the Study of the Liver.
[16] M. Brunetto,et al. Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases. , 2008, World journal of gastroenterology.
[17] M. Sawabe,et al. Undiagnosed cirrhosis occurs frequently in the elderly and requires periodic follow ups and medical treatments , 2008, Geriatrics & gerontology international.
[18] F. Carrat,et al. How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited. , 2008, Clinical chemistry.
[19] N. Afdhal,et al. Diagnosis and quantitation of fibrosis. , 2008, Gastroenterology.
[20] H. Kirikoshi,et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[21] V. de Lédinghen,et al. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. , 2007, Clinical chemistry.
[22] Berkman Sahiner,et al. Classifier Performance Estimation Under the Constraint of a Finite Sample Size: Resampling Schemes Applied to Neural Network Classifiers , 2007, IJCNN.
[23] Olivia T. Abar,et al. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C , 2007, Hepatology.
[24] Xiao-Hua Zhou,et al. Multiple imputation: review of theory, implementation and software , 2007, Statistics in medicine.
[25] R. Sacco,et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases , 2007, Journal of viral hepatitis.
[26] T. Therneau,et al. The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.
[27] J. Iredale. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. , 2007, The Journal of clinical investigation.
[28] Dario Conte,et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease , 2007, Gut.
[29] T. Stijnen,et al. Review: a gentle introduction to imputation of missing values. , 2006, Journal of clinical epidemiology.
[30] J. Montaner,et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.
[31] Nancy A Obuchowski,et al. Estimating and comparing diagnostic tests' accuracy when the gold standard is not binary. , 2005, Academic radiology.
[32] P. Giral,et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. , 2005, Gastroenterology.
[33] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[34] Yvonne Vergouwe,et al. Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. , 2005, Journal of clinical epidemiology.
[35] D. Thabut,et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. , 2004, Clinical chemistry.
[36] Amitabh Chak,et al. Prediction of outcome in acute lower-gastrointestinal haemorrhage based on an artificial neural network: internal and external validation of a predictive model , 2003, The Lancet.
[37] J. Kalbfleisch,et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.
[38] Llorenç Quintó,et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model , 2002, Hepatology.
[39] E. Schiff,et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection , 2002, American Journal of Gastroenterology.
[40] A. Zanella,et al. Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels , 2002, Annals of Internal Medicine.
[41] James R. Dixon,et al. The International Conference on Harmonization Good Clinical Practice guideline. , 1999, Quality assurance.
[42] P. Bedossa,et al. An algorithm for the grading of activity in chronic hepatitis C , 1996, Hepatology.
[43] W. Baxt. Application of artificial neural networks to clinical medicine , 1995, The Lancet.
[44] N. Graudal,et al. Characteristics of cirrhosis undiagnosed during life: a comparative analysis of 73 undiagnosed cases and 149 diagnosed cases of cirrhosis, detected in 4929 consecutive autopsies , 1991, Journal of internal medicine.
[45] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[46] E. Tapper,et al. FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[47] G. D’Amico,et al. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. , 2006, Journal of hepatology.
[48] R. Lewis. An Introduction to Classification and Regression Tree (CART) Analysis , 2000 .
[49] Peter E. Hart,et al. Nearest neighbor pattern classification , 1967, IEEE Trans. Inf. Theory.